We are live on ! Find out more
SC

Saturna Capital Portfolio holdings

AUM $7.13B
1-Year Est. Return 35.47%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
+35.47%
3 Year Est. Return
+92.6%
5 Year Est. Return
+130.56%
10 Year Est. Return
+515.97%
AUM
$3.12B
AUM Growth
-$22.9M
Cap. Flow
-$50.6M
Cap. Flow %
-1.62%
Top 10 Hldgs %
26.9%
Holding
158
New
1
Increased
20
Reduced
36
Closed
2

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$6.31M
2
ABBV icon
AbbVie
ABBV
+$2.86M
3
TRMB icon
Trimble
TRMB
+$701K
4
RIO icon
Rio Tinto
RIO
+$560K
5
DD icon
DuPont de Nemours
DD
+$494K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$30M
2
LLY icon
Eli Lilly
LLY
+$13.1M
3
NKE icon
Nike
NKE
+$7.7M
4
PG icon
Procter & Gamble
PG
+$4.52M
5
GIS icon
General Mills
GIS
+$4.38M

Sector Composition

Rank Sector Weight
1 Technology 29.55%
2 Industrials 21.17%
3 Healthcare 19.22%
4 Consumer Staples 12.58%
5 Materials 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KEYS icon
51
Keysight
KEYS
$54.5B
$29.9M 0.96%
506,179
– –
FAST icon
52
Fastenal
FAST
$54B
$29.1M 0.93%
2,421,656
+2,400
+0.1% +$31.1K
ABT icon
53
Abbott
ABT
$180B
$26.5M 0.85%
433,960
-763
-0.2% -$46.3K
GWW icon
54
W.W. Grainger
GWW
$65.3B
$25.2M 0.81%
81,600
– –
RTX icon
55
RTX Corp
RTX
$287B
$25.2M 0.81%
319,686
– –
KMB icon
56
Kimberly-Clark
KMB
$36.4B
$24.4M 0.78%
231,600
-100
-0% -$10.4K
IT icon
57
Gartner
IT
$9.41B
$24M 0.77%
180,741
– –
UL icon
58
Unilever
UL
$131B
$22.9M 0.73%
368,178
– –
GIS icon
59
General Mills
GIS
$19.2B
$22.3M 0.72%
504,588
-100,000
-17% -$4.38M
NVS icon
60
Novartis
NVS
$295B
$21.9M 0.7%
323,225
-434,793
-57% -$30M
MEOH icon
61
Methanex
MEOH
$4.32B
$21.7M 0.7%
307,000
– –
SJM icon
62
J.M. Smucker
SJM
$12.6B
$19.9M 0.64%
185,000
– –
CELG
63
DELISTED
Celgene Corp
CELG
$16.8M 0.54%
212,114
-120
-0.1% -$9.96K
JCI icon
64
Johnson Controls International
JCI
$87.5B
$16.7M 0.54%
500,725
-813
-0.2% -$28.2K
SWK icon
65
Stanley Black & Decker
SWK
$14.2B
$14.8M 0.47%
111,144
– –
GSK icon
66
GSK
GSK
$103B
$14.3M 0.46%
283,606
– –
RPM icon
67
RPM International
RPM
$13.7B
$12.1M 0.39%
207,286
+280
+0.1% +$14K
XRAY icon
68
Dentsply Sirona
XRAY
$2.59B
$9.46M 0.3%
216,140
– –
NTR icon
69
Nutrien
NTR
$32.7B
$8.86M 0.28%
162,892
– –
CVG
70
DELISTED
Convergys
CVG
$8.59M 0.28%
351,383
– –
NICE icon
71
Nice
NICE
$5.29B
$4.2M 0.13%
40,440
– –
TD icon
72
Toronto Dominion Bank
TD
$198B
$3.94M 0.13%
68,170
– –
PG icon
73
Procter & Gamble
PG
$343B
$3.84M 0.12%
49,211
-60,000
-55% -$4.52M
TTE icon
74
TotalEnergies
TTE
$193B
$3.35M 0.11%
55,401
– –
CPA icon
75
Copa Holdings
CPA
$5.56B
$3.23M 0.1%
34,100
– –
1 2
3
4 5

Similar funds

FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $7.06B AUM 28.93% 1-Year Est. Return

Saturna Capital's Q2 2018 Portfolio in Review

As of Q2 2018, Saturna Capital held 158 positions worth $3.12B, down 0.73% from $3.14B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Trading was light in Q2 2018: portfolio turnover was 1.9%. Saturna Capital opened 1 new position and exited 2, leaving the 158-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Industrials and Healthcare.

  • Saturna Capital's largest Q2 2018 buy was Enbridge: 5,980 shares worth $213K.
  • Saturna Capital added most to Johnson & Johnson in Q2 2018, an estimated $6.31M increase.
  • Saturna Capital's biggest Q2 2018 reduction was Novartis, cutting an estimated $30M.
  • Saturna Capital fully exited CVS Health in Q2 2018, selling an estimated $635K.
  • Saturna Capital's ten largest holdings make up 27% of its $3.12B portfolio in Q2 2018.
  • Saturna Capital opened 1 new position and closed 2 in Q2 2018.
  • Saturna Capital's portfolio value fell 0.73% quarter-over-quarter to $3.12B.

Based on Saturna Capital's 13F filing for Q2 2018, filed 2 Aug 2018.